BeiGene Ltd (BGNE)
161.02
-7.59
(-4.50%)
USD |
NASDAQ |
May 10, 16:00
161.02
0.00 (0.00%)
After-Hours: 20:00
BeiGene Cash from Investing (TTM): -390.89M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -390.89M |
| December 31, 2023 | 60.00M |
| September 30, 2023 | 161.12M |
| June 30, 2023 | 516.88M |
| March 31, 2023 | 1.108B |
| December 31, 2022 | 1.077B |
| September 30, 2022 | 1.148B |
| June 30, 2022 | 966.22M |
| March 31, 2022 | 559.10M |
| December 31, 2021 | 640.66M |
| September 30, 2021 | 444.62M |
| June 30, 2021 | -1.080B |
| March 31, 2021 | -1.761B |
| December 31, 2020 | -3.168B |
| September 30, 2020 | -3.105B |
| June 30, 2020 | -1.355B |
| March 31, 2020 | -733.22M |
| Date | Value |
|---|---|
| December 31, 2019 | 554.16M |
| September 30, 2019 | 791.30M |
| June 30, 2019 | 87.03M |
| March 31, 2019 | -70.84M |
| December 31, 2018 | -637.61M |
| September 30, 2018 | -919.10M |
| June 30, 2018 | -829.79M |
| March 31, 2018 | -794.21M |
| December 31, 2017 | -356.32M |
| September 30, 2017 | -458.80M |
| June 30, 2017 | -13.39M |
| March 31, 2017 | -218.65M |
| December 31, 2016 | -221.85M |
| September 30, 2016 | -43.83M |
| June 30, 2016 | -81.65M |
| March 31, 2016 | -21.79M |
| December 31, 2015 | -58.91M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-3.168B
Minimum
Dec 2020
1.148B
Maximum
Sep 2022
-174.03M
Average
302.87M
Median
Cash from Investing (TTM) Benchmarks
| Theravance Biopharma Inc | -32.70M |
| LumiraDx Ltd | -10.81M |
| Dr Reddy's Laboratories Ltd | -486.60M |
| ASLAN Pharmaceuticals Ltd | -- |
| Zai Lab Ltd | 46.47M |